Due to the widespread use of screening, the incidence of cervical cancer has decreased significantly. Precancerous lesions can be identified and removed before they become cancerous. In 2010, approximately 12,200 patients were diagnosed with cervical cancer in the United States. About 4,210 people will die from this disease.
Screening tests include traditional Pap smears or fluid cytology with or without DNA testing for HPV (human papillomavirus). You can get the best information about cancer screening in Kenya via https://www.jacarandamaternity.co.ke/cervical-cancer.
Image Source: Google
The current recommendations from the American College of Obstetricians and Gynecologists for women at normal risk are as follows:
1) The smear board starts at the age of 21
2) <30 years: every 2 years
3)> 30 years: every 3 years
4) Stop screening at age 65-70 years after 3 normal tests in the last 10 years.
Screening is more common in women at high risk. High-risk diseases include previous cervical cancer, exposure to DES (diethylstilbestrol) as a fetus, and immune system conditions (from transplant drugs, chemotherapy, steroids, or HIV). Please note that the above screening recommendations apply to "asymptomatic" patients.
If you feel you are experiencing new symptoms such as unusual bleeding, profuse discharge, pelvic pain, painful urination, etc., discuss this with your doctor. With the recent development of vaccines, cervical cancer is now also a potentially preventable disease.